| By Global Leaders Institute |
| Friday, 13 November 2009 |
 |
The pharma and biotech sectors are at a pivotal point in their evolution. The companies are facing significant pressure to change with thinning
|
|
pipelines, skyrocketing R&D costs, calls for lower prices and a greater regulatory burden, these conditions together with the financial crisis have made the work of creating new drugs harder than ever. Big pharmaceutical companies are being forced to globalize their R&D operations, especially to emerging markets.
Under this background, leaders of pharma and biotech companies from around the world will gather in |
|
|
Shanghai on March 4-5, 2010 at Asia Pharma R&D Leaders 2010 for strategies to capitalize on the enormous opportunity the booming Asia Market provides.
This event focuses on the operational, regulatory, and strategic challenges of outsourcing your drug discovery work to Asia. Plus, the event sets up an effective platform for you to meet face to face with a variety of Asia's local CROs and leading clinical practitioners to discuss the specifics of your outsourcing requirements.
An international audience consisting of senior-level pharma and biotech executives from the R&D, clinical
|
|
development, business development, global market access, licensing, and regulatory affairs functions will be in attendance.
For the full program and list of companies scheduled to attend,
please visit the event website at http://www.aprdl.com.
Want to read more?
FMC Corporation Names Pierre Brondeau President and Chief Executive Officer
WuXi AppTec Receives 2009 Schering-Plough Excellence Award
Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China |
|
|
